Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Marketing
AstraZeneca and Merck's Lynparza set to 'dominate' PARP market
AZ and Merck were the first to grab an FDA approval for Lynparza, and, despite growing competition, the drug is set to remain top in the PARP space.
Ben Adams
Apr 24, 2024 8:23am
AstraZeneca taps hard-hitting NHL star for cancer screening push
Apr 19, 2024 12:00pm
AZ's Alexion debuts short film highlighting NMOSD community
Apr 18, 2024 2:16pm
Inside #FierceMadness winner Wainua's 'phonetic appeal'
Apr 15, 2024 4:16pm
AstraZeneca cries havoc over CKD's hit on economies, environment
Apr 15, 2024 8:00am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am